Recurrent Urinary Tract Infection Vaccine Referral

Authored by
Last reviewed
April 30, 2024
Content Overview
UTI oral spray Uromune MV140 vaccine is offered in various countries in 2024

Recurrent Urinary Tract Infection Vaccine (rUTI) Referral

The Uromune™ MV140 vaccine experimental Recurrent Urinary Tract Infection (rUTI) inactivated oral spray vaccine is approved for use by adults in various countries. Uromune initially became available in Spain and is now available in 26 countries, including Canada, England, Europe, and Mexico.

Please complete the form below to receive a rUTI vaccine referral. Please note that as of April 2024, Uromune is not available in the United States. This means that to become immunized against rUTIs, you would need to travel internationally.

This self-administered rUTI vaccine contains four whole-cell inactivated bacteria suspended in water. Uromine vaccination has been found in research to reduce the number of UTIs by about 70% and increase the time to the next UTI from 48 days to 275 days.


Travel Vaccinations Services 2024

While traveling abroad in 2024, various health agencies recommend travel vaccines when visiting disease-endemic areas.

Please click on this PVax link to request a pre-departure travel vaccination counseling session: